Skip to main content

Table 3 Clinical characteristics of LN patients

From: Hsa_circ_0123190 acts as a competitive endogenous RNA to regulate APLNR expression by sponging hsa-miR-483-3p in lupus nephritis

  Serum
Pt Age (years) Disease duration (months) C3 (g/L) C4 (g/L) ESR (mm/h) CRP (mg/L) WBC (*10^9/L) RBC (*10^12/L) Hb (g/L) PLT (*10^9/L)
1 39 144 0.43 0.06 37 3.06 2.80 3.09 89.0 104
2 38 48 0.65 0.11 27 3.13 3.64 4.15 116.8 209
3 34 19 0.59 0.10 60 54.83 6.40 2.69 81.0 96
4 20 36 0.19 0.07 3 3.23 2.32 3.90 115.9 128
5 23 6 1.03 0.15 12 3.13 5.56 5.46 117.8 221
6 35 36 0.25 0.07 38 3.13 2.13 3.30 103.3 106
7 19 60 0.56 0.11 10 3.13 4.60 2.37 74.0 110
8 48 156 0.34 0.08 14 1.00 5.40 2.84 85.0 80
9 36 1 0.33 0.05 11 9.00 2.10 3.45 105.0 136
10 46 120 0.62 0.05 74 32.52 3.50 3.14 98.0 227
  Serum Urine Renal biopsy SLEDAI (score)
Pt Creatinine (umol/L) Urea (mmol/L) eGFR (mL/min /1.73m2) UTP (g/24 h) RBC (/uL) WBC (/uL) Classification AI (score) CI (score)
1 59 5.03 111.223 8.30 95 56 IV-S(A) + V 9 0 9
2 63 4.50 107.899 2.52 26 4 III-(A) 8 1 8
3 130 12.44 46.224 6.03 252 94 IV-G(A) + V 19 3 11
4 51 3.85 133.345 2.07 50 0 III-(A/C) 6 1 12
5 58 7.11 109.314 2.03 50 0 III-(A) + V 0 0 6
6 135 12.40 38.299 6.25 92 22 IV-G(A/C) 10 2 4
7 77 4.90 96.472 2.82 350 12 IV-S(A) 9 0 8
8 56 10.36 98.682 6.39 45 22 IV-G(A) 15 0 5
9 69 4.31 98.028 2.35 184 50 IV-S(A) 9 0 4
10 59 6.91 93.006 1.40 37 28 IV-S(A) 7 0 4
  1. Pt patient, WBC white blood cells, RBC red blood cells, Hb hemoglobin, PLT Platelet, C3 complement 3, C4 complement 4, AI activity index, CI chronicity index, eGFR estimated glomerular filtration rate based on CKD-EPI formula, SLEDAI systemic lupus erythematosus disease activity index, UTP urinary total proteinuria per day